CLASS III Drug recall · Reported 10 Jul 2019 · FDA Enforcement Report

Testosterone Topical Solution 30mg of testosterone per pump recalled

InvaGen Pharmaceuticals is recalling Testosterone Topical Solution 30mg of testosterone per pump actuation * each actuation, distributed nationwide in the US. The recall was initiated on 12 Jun 2019 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot GH80480 and GH80481, exp 3/2020
NDC69097-363
Quantity recalled1776 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1454-2019
FDA event ID
83117
Recalling firm
InvaGen Pharmaceuticals, Central Islip, NY
Manufacturer
Cipla USA Inc.
Classification
Class III
Status
Terminated
Recall initiated
12 Jun 2019
FDA classified
3 Jul 2019
Reported
10 Jul 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

12 Jun 2019Recall initiated by company
3 Jul 2019Classified by FDA+21 days
10 Jul 2019Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Defective Container; actuator may improperly function and affect dose delivery.

Product as listed by the FDA

Testosterone Topical Solution 30mg of testosterone per pump actuation * each actuation delivers 1.5 mL of solution Total contents: 110 mL to deliver 90 mL, Manufactured by: Cipla Ltd, Verna Goa, India Manufactured for: Cipla USA, Inc., Sunrise, FL 33323 NDC 69097-363-44

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Defective Container; actuator may improperly function and affect dose delivery.

Which lots are affected?

Lot GH80480 and GH80481, exp 3/2020

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from InvaGen Pharmaceuticals

All 11

Other Testosterone recalls

All 91